Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 24 Jul 20 424B5 Prospectus supplement for primary offering
- 23 Jul 20 EFFECT Notice of effectiveness
- 22 Jul 20 F-1/A Registration statement (foreign) (amended)
- 22 Jul 20 FWP Free writing prospectus
-
21 Jul 20 F-1 Registration statement (foreign)
BNTX similar filings
- 23 Jul 20 Registration statement (foreign) (amended)
- 22 Jul 20 Registration statement (foreign) (amended)
- 21 Jul 20 Registration statement (foreign)
- 21 Jul 20 Registration statement (foreign)
- 3 Feb 20 Registration statement (foreign)
- 9 Oct 19 Registration statement (foreign) (amended)
- 4 Oct 19 Registration statement (foreign) (amended)
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 31, 2020, in the Registration Statement (Form F-1) and related Prospectus of BioNTech SE for the registration of its ordinary shares.
We also consent to the incorporation by reference therein of our report dated March 31, 2020 with respect to the financial statements of BioNTech SE for the years ended December 31, 2019, 2018, and 2017 included in the Annual Report (Form 20-F) for 2019 filed with the Securities and Exchange Commission.
/s/ Titus Zwirner | /s/ Andreas Weigel | |
Wirtschaftsprüfer | Wirtschaftsprüfer | |
(German Public Auditor) | (German Public Auditor) |
Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft
Cologne, Germany
July 21, 2020